BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8310976)

  • 1. Measurement of long-term hemodynamic changes and the use of 24-hour blood pressure monitoring to evaluate treatment.
    Lund-Johansen P; Omvik P; White W
    Am J Cardiol; 1994 Jan; 73(3):44A-49A. PubMed ID: 8310976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    Cardiology; 1992; 80 Suppl 1():37-45. PubMed ID: 1534714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term haemodynamic effects of amlodipine at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P; White W; Digranes O; Helland B; Jordal O; Stray T
    J Hypertens; 1990 Dec; 8(12):1129-36. PubMed ID: 1962802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term hemodynamic effects at rest and during exercise of newer antihypertensive agents and salt restriction in essential hypertension: review of epanolol, doxazosin, amlodipine, felodipine, diltiazem, lisinopril, dilevalol, carvedilol, and ketanserin.
    Omvik P; Lund-Johansen P
    Cardiovasc Drugs Ther; 1993 Apr; 7(2):193-206. PubMed ID: 8395198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of amlodipine and captopril on clinic and ambulatory blood pressure.
    Lacourcière Y; Poirier L; Provencher P
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S25-8. PubMed ID: 1293305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of amlodipine and long-acting diltiazem in the treatment of mild or moderate hypertension.
    Horwitz LD; Weinberger HD; Clegg L
    Am J Hypertens; 1997 Nov; 10(11):1263-9. PubMed ID: 9397246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the effects of manidipine on the diurnal variation of arterial pressure and hemodynamics in patients with essential hypertension.
    Iwata A; Tochikubo O; Kawano Y; Minamisawa K; Miyakawa Y; Ishii M
    Blood Press Suppl; 1992; 3():87-93. PubMed ID: 1343298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial monitoring of the antihypertensive effects of once-daily amlodipine.
    Broadhurst P; Heber ME; Brigden G; al-Khawaja I; Raftery EB
    J Hum Hypertens; 1992 Dec; 6 Suppl 1():S9-12. PubMed ID: 1293307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of amlodipine. A new once-daily calcium antagonist in non-hypertensive patients with coronary artery disease.
    Ogawa T; Yasui K; Tomizawa T; Sugishita Y
    Jpn Heart J; 1993 Sep; 34(5):557-65. PubMed ID: 8301842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amlodipine on platelet aggregation and blood pressure in patients with essential hypertension.
    Hernández R; Carvajal AR; Armas-de Hernandez MJ; Guerrero-Pajuelo J; Armas-Padilla MC; Barragan O; Machado-de Alvarado I
    Clin Ther; 1993; 15(2):304-13. PubMed ID: 8519039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of verapamil in essential hypertension at rest and during exercise.
    Lund-Johansen P
    Acta Med Scand Suppl; 1984; 681():109-15. PubMed ID: 6587749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.
    Lund-Johansen P
    Br J Clin Pharmacol; 1976 Jun; 3(3):445-51. PubMed ID: 973971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular structural changes and calcium antagonist therapy in patients with hypertension.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Zulli R; Calebich S; Castellano M; Cavaliere G; Nordio G; Pasini F; Zuccato F
    J Cardiovasc Pharmacol; 1994; 24 Suppl A():S37-43. PubMed ID: 7603076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol.
    Lund-Johansen P
    J Cardiovasc Pharmacol; 1979; 1(5):487-95. PubMed ID: 94405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.